A. Johri, L. Paoletti, P. Glaser, M. Dua, P. Sharma et al., Group B Streptococcus: global incidence and vaccine development, Nature Reviews Microbiology, vol.60, issue.12, pp.932-974, 2006.
DOI : 10.1038/nrmicro1552

D. Blancas, M. Santin, M. Olmo, F. Alcaide, J. Carratala et al., Group B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology, pp.168-73, 2004.

L. Jackson, R. Hilsdon, M. Farley, L. Harrison, A. Reingold et al., Risk Factors for Group B Streptococcal Disease in Adults, Annals of Internal Medicine, vol.123, issue.6, pp.415-435, 1995.
DOI : 10.7326/0003-4819-123-6-199509150-00003

M. Farley, Group B Streptococcal Disease in Nonpregnant Adults, Clinical Infectious Diseases, vol.33, issue.4, pp.556-61, 2001.
DOI : 10.1086/322696

T. Skoff, M. Farley, S. Petit, A. Craig, W. Schaffner et al., Increasing burden of invasive group B streptococcal disease in nonpregnant adults Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, pp.85-92, 1990.

S. Schrag, S. Zywicki, M. Farley, A. Reingold, L. Harrison et al., Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis, New England Journal of Medicine, vol.342, issue.1, pp.15-20, 2000.
DOI : 10.1056/NEJM200001063420103

D. Cunha, V. Davies, M. Douarre, P. Rosinski-chupin, I. Margarit et al., Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline, Nature communications, vol.5, p.4538795, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01299769

H. Bergseng, M. Rygg, L. Bevanger, and K. Bergh, Invasive group B streptococcus (GBS) disease in Norway European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology, pp.1193-1202, 1996.

E. Martins, J. Melo-cristino, and M. Ramirez, Dominance of Serotype Ia among Group B Streptococci Causing Invasive Infections in Nonpregnant Adults in Portugal, Journal of Clinical Microbiology, vol.50, issue.4, pp.1219-1246, 2012.
DOI : 10.1128/JCM.05488-11

A. Tazi, P. Morand, H. Reglier-poupet, N. Dmytruk, A. Billoet et al., Invasive group B streptococcal infections in adults, France Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, pp.1587-1596, 2007.

M. Edwards, Group B streptococcal conjugate vaccine: A timely concept for which the time has come, Human Vaccines, vol.4, issue.6, pp.444-452, 2008.
DOI : 10.4161/hv.4.6.6507

P. Madureira, E. Andrade, B. Gama, L. Oliveira, S. Moreira et al., Inhibition of IL-10 Production by Maternal Antibodies against Group B Streptococcus GAPDH Confers Immunity to Offspring by Favoring Neutrophil Recruitment, PLoS Pathogens, vol.41, issue.Pt 1, p.3219712, 2011.
DOI : 10.1371/journal.ppat.1002363.s005

R. Forster, Study designs for the nonclinical safety testing of new vaccine products, Journal of Pharmacological and Toxicological Methods, vol.66, issue.1, pp.1-7, 2012.
DOI : 10.1016/j.vascn.2012.04.003

P. Madureira, M. Baptista, M. Vieira, V. Magalhaes, A. Camelo et al., Streptococcus agalactiae GAPDH Is a Virulence-Associated Immunomodulatory Protein, The Journal of Immunology, vol.178, issue.3, pp.1379-87, 2007.
DOI : 10.4049/jimmunol.178.3.1379
URL : https://hal.archives-ouvertes.fr/hal-00132018

H. Talke and G. Schubert, Enzymatische Harnstoffbestimmung in Blut und Serum im optischen Test nachWarburg, Klinische Wochenschrift, vol.202, issue.3, pp.174-179, 1965.
DOI : 10.1007/BF01484513

D. Fabiny and G. Ertingshausen, Automated reaction-rate method for determination of serum creatinine with the CentrifiChem, Clinical chemistry, vol.17, issue.8, pp.696-700, 1971.

R. Dinis-oliveira, C. Sousa, F. Remiao, J. Duarte, A. Navarro et al., Full survival of paraquat-exposed rats after treatment with sodium salicylate. Free radical biology & medicine, pp.1017-1045, 2007.

K. Hayashi, R. Kojima, and M. Ito, Strain Differences in the Diabetogenic Activity of Streptozotocin in Mice, Biological & Pharmaceutical Bulletin, vol.29, issue.6, pp.1110-1119, 2006.
DOI : 10.1248/bpb.29.1110

S. Kim, W. Yang, S. Lee, H. Chi, and J. Park, Effect of increasing serum albumin on haemostatic factors synthesized in the liver in CAPD patients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association?European Renal Association, pp.2053-2061, 1998.

H. Bozbas, A. Yildirir, and H. Muderrisoglu, Cardiac Enzymes, Renal Failure and Renal Transplantation, Clinical Medicine & Research, vol.4, issue.1, pp.79-8479, 2006.
DOI : 10.3121/cmr.4.1.79

A. Obianime and I. Roberts, Antioxidants, cadmium-induced toxicity, serum biochemical and the histological abnormalities of the kidney and testes of the male Wistar rats. Nigerian journal of physiological sciences: official publication of the Physiological Society of Nigeria, pp.177-85, 2009.

W. Matull, S. Pereira, O. Donohue, and J. , Biochemical markers of acute pancreatitis, Journal of Clinical Pathology, vol.59, issue.4, pp.340-344, 2006.
DOI : 10.1136/jcp.2002.002923

A. Bernard and R. Lauwerys, Low-molecular-weight proteins as markers of organ toxicity with special reference to Clara cell protein, Toxicology Letters, vol.77, issue.1-3, pp.1-3145, 1995.
DOI : 10.1016/0378-4274(95)03284-3

C. Watterson, A. Lanevschi, J. Horner, and C. Louden, A Comparative Analysis of Acute-phase Proteins as Inflammatory Biomarkers in Preclinical Toxicology Studies: Implications for Preclinical to Clinical Translation, Toxicologic Pathology, vol.37, issue.1, pp.28-33, 2009.
DOI : 10.1177/0192623308329286

D. Chen and D. Zehrung, Desirable Attributes of Vaccines for Deployment in Low-Resource Settings, Journal of Pharmaceutical Sciences, vol.102, issue.1, pp.29-33, 2013.
DOI : 10.1002/jps.23352

S. Zeissig and R. Blumberg, Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease, Nature Immunology, vol.37, issue.4, 2014.
DOI : 10.1038/ni.2847

H. Jordan, M. Farley, A. Craig, J. Mohle-boetani, L. Harrison et al., Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease, The Pediatric Infectious Disease Journal, vol.27, issue.12, pp.1057-64, 2008.
DOI : 10.1097/INF.0b013e318180b3b9

S. Black, I. Margarit, and R. Rappuoli, Preventing Newborn Infection with Maternal Immunization, Science Translational Medicine, vol.5, issue.195, 0195.
DOI : 10.1126/scitranslmed.3005451

C. Baker and D. Kasper, Group B Streptococcal Vaccines, Clinical Infectious Diseases, vol.7, issue.4, pp.458-67, 1985.
DOI : 10.1093/clinids/7.4.458

C. Baker and D. Kasper, Correlation of Maternal Antibody Deficiency with Susceptibility to Neonatal Group B Streptococcal Infection, New England Journal of Medicine, vol.294, issue.14, pp.753-759, 1976.
DOI : 10.1056/NEJM197604012941404

C. Lachenauer, D. Kasper, J. Shimada, Y. Ichiman, H. Ohtsuka et al., Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. The Journal of infectious diseases, pp.1030-1033, 1999.

E. Persson, S. Berg, B. Trollfors, P. Larsson, E. Ek et al., Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, pp.791-797, 1998.

S. Bellais, A. Six, A. Fouet, M. Longo, N. Dmytruk et al., Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. The Journal of infectious diseases, pp.1745-52, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01300172

J. Palmeiro, D. Carvalho, N. Botelho, A. Fracalanzza, S. Madeira et al., Maternal group B streptococcal immunization: Capsular polysaccharide (CPS)-based vaccines and their implications on prevention, Vaccine, vol.29, issue.21, p.21414381, 2011.
DOI : 10.1016/j.vaccine.2011.02.102

I. Margarit, C. Rinaudo, C. Galeotti, D. Maione, C. Ghezzo et al., Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. The Journal of infectious diseases, pp.108-123, 2009.

S. Hill and J. Davies, : reassessing the old paradigms, FEMS Microbiology Reviews, vol.33, issue.3, pp.521-551, 2009.
DOI : 10.1111/j.1574-6976.2009.00171.x

P. Domingo, N. Barquet, M. Alvarez, P. Coll, J. Nava et al., Group B streptococcal meningitis in adults: report of twelve cases and review. Clinical infectious diseases: an official publication of the Infectious Diseases Society of, America, vol.25, issue.5, pp.1180-1187, 1997.

A. Sambola, J. Miro, M. Tornos, B. Almirante, A. Moreno-torrico et al., Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, pp.1576-84, 1962.

L. Oliveira, P. Madureira, E. Andrade, A. Bouaboud, E. Morello et al., Group B Streptococcus GAPDH Is Released upon Cell Lysis, Associates with Bacterial Surface, and Induces Apoptosis in Murine Macrophages, PLoS ONE, vol.186, issue.Pt 8, 2012.
DOI : 10.1371/journal.pone.0029963.s004
URL : https://hal.archives-ouvertes.fr/pasteur-01300175

C. Jeffery, Moonlighting proteins???an update, Molecular BioSystems, vol.30, issue.9, pp.345-50, 2009.
DOI : 10.1039/b900658n

V. Magalhaes, E. Andrade, J. Alves, A. Ribeiro, K. Kim et al., Group B Streptococcus Hijacks the Host Plasminogen System to Promote Brain Endothelial Cell Invasion, PLoS ONE, vol.285, issue.5, p.3642152, 2013.
DOI : 10.1371/journal.pone.0063244.g005
URL : https://hal.archives-ouvertes.fr/pasteur-01300161

K. Seifert, W. Mcarthur, A. Bleiweis, and L. Brady, Characterization of group B streptococcal glyceraldehyde-3-phosphate dehydrogenase: surface localization, enzymatic activity, and protein??protein interactions, Canadian Journal of Microbiology, vol.49, issue.5, pp.350-356, 2003.
DOI : 10.1139/w03-042

A. Henningham, E. Chiarot, C. Gillen, J. Cole, M. Rohde et al., Conserved anchorless surface proteins as group A streptococcal vaccine candidates, Journal of Molecular Medicine, vol.162, issue.10, pp.1197-207, 2012.
DOI : 10.1007/s00109-012-0897-9

E. Ling, G. Feldman, M. Portnoi, R. Dagan, K. Overweg et al., Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse, Clinical and Experimental Immunology, vol.72, issue.2, pp.290-298, 2004.
DOI : 10.1128/IAI.70.2.851-858.2002

M. Dinis, D. Tavares, I. Veiga-malta, A. Fonseca, E. Andrade et al., Recombinant Enolase Confers Protection against Dental Caries in Rats, Journal of Infectious Diseases, vol.199, issue.1, pp.116-139, 2009.
DOI : 10.1086/594372

Y. Feng, X. Pan, W. Sun, C. Wang, H. Zhang et al., Enolase Functions as a Protective Antigen Displayed on the Bacterial Cell Surface, The Journal of Infectious Diseases, vol.200, issue.10, pp.1583-92, 2009.
DOI : 10.1086/644602

P. Barrow, Developmental and reproductive toxicity testing of vaccines, Journal of Pharmacological and Toxicological Methods, vol.65, issue.2, pp.58-63, 2012.
DOI : 10.1016/j.vascn.2011.12.001

P. Palmeira, C. Quinello, A. Silveira-lessa, C. Zago, and M. Carneiro-sampaio, IgG Placental Transfer in Healthy and Pathological Pregnancies, Clinical and Developmental Immunology, vol.182, issue.1, part 1, pp.985646-3251916, 2012.
DOI : 10.1034/j.1399-3038.2001.012002059.x

I. Knezevic, Stability evaluation of vaccines: WHO approach, Biologicals, vol.37, issue.6, pp.357-366, 2009.
DOI : 10.1016/j.biologicals.2009.08.004